Constantly looking for undervalued gems.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If they own the trademark name (isopet) they have a claim to fight. This is called domain squatting and it’s illegal in the US.
http://www.icann.org/en/help/dndr/udrp
It’s really not that hard, you either believe they are telling the truth with regard to attacking tumors with their technology and the results that they have shown or you don’t. You either believe the test results and the promise of what that could mean within the field of veterinary medicine or you don’t. That’s why stocks are speculative. We all know this company‘s history, and if it had played out differently, the stock would be at $.50 or a dollar. We shall see if they are able to make it happen this time around. It’s simply risk versus reward, nothing more.
Lowest volume day today in many months. Everyone that wanted to leave has left. The spring is winding tighter everyday here.
Understanding biotech startup business models is critical for anyone investing in this. They need access to money on favorable terms in order to continue their r&d as well as operationalize their treatment platform and roll it out to clinics. That’s why capital is required at this point.
The treatment results look good based on the press releases, so things seem on track. The other data points include patients like Moose who folks can follow on other social media channels. So far so good based on what has been shared. One day at a time.
I think you are right! The volume and price appreciation has brought a lot of attention this week. We are looking strong going into today.
It's showing a very similar pattern. Tomorrow will be fun.
They are letting it run higher. It could get to .05 quick tomorrow if this keeps up.
It's got strength like I haven't seen in a long time. Tomorrow should be interesting. It's closing strong into the final hour.
Lots of buys coming in now. This has the makings of last summer. We could see a major push later today and huge volume in price appreciation tomorrow.
Looks like we are on track to double daily average 10 day volume. Lots of attention will come here after traders do their research tonight. Tomorrow could be a very good day. Just like old times.
New highs of the day printing. Lots of eyes on this.
Nice volume. History repeating from last year. Should touch 1 year highs with news this spring of progress. Looking good.
Yes it's a tired act but it is par for the course on these boards
Thanks for the heads up. Enjoy your day.
Maybe not more news, but just a delayed reaction to recent events announced through the past few press releases. It was clearly oversold and beaten down and this ticker still has name recognition from being on so many radar screens with the huge move up last year. Now they are one year closer with more financing and more positive test results.
This will climb like last year. It's just a matter of seeing substance around the patents and prep for trials. One step at a time.
Exactly. Until then. Patience.
No fooling me??. Long and strong... Still!
Won't be selling but thanks anyway. Have a lovely day!
No one would spend as much time and effort, as some do here, without an agenda. It's obvious.
Correct, misleading because he quoted preclinical study results. Not guilty of anything else. And certainly not suspended.
Panel found that he was NOT dishonest. Read it carefully. They basically said his exuberance around the effectiveness was misleading. He was Not suspended. Repeat. NOT suspended. The guy needs to work on his communication skills... Nothing more.
Hey doc, some of us still believe, so no worries. Patience will be rewarded.
Thanks Rake...appreciate you informing us. What's your gut feel on Maxim action. 1 week? 1 month? Thanks!
Yes it would be good to use a consistent news service provider with the proper reach that a small company like PPCH that has excellent news to disseminate. That's a good investment for their money.
Sub penny. Never.
That won't happen. But wishful nonetheless.
Agreed. Look at the past several months. The action was multi day bumps of 20 or 30 percent almost daily for several days after significant news.
Thanks. They must not be using a service that allows the big brokers to pick up the PR timely.
I'm still curious why some entities have not picked up the news. Both Etrade and fidelity trading platforms do not show any news for PPCH. I wonder if management needs to enlist in a better Service for PR's.
At this point it's clear that anyone who claims that the results are not real is just embarrassing themselves. They need to give it a rest as they don't realize how ridiculous they look.
Truth!
The significance of "real medical need" in the below quote cannot be stressed enough. This is bigger than most think. These cancers kill indiscriminately and there aren't many options. If PPCH gives doctors another option to help attack these aggressive tumors, the sky is the limit.
"Research and development activities with our research partners into the effects of PRP are progressing well and we are very pleased with the results, especially when PRP responds to cancer types where a real medical need exists," said James Nathanielsz, Propanc's Chief Executive Officer.
I wonder what they use to distribute news?? Could be something for them to improve upon...
The news hasn't hit on some trading platforms yet. Fidelity is not showing it. Etrade is not showing it. Not on ihub....I'm not sure why...
Awesome news! Let's go...
The share price should be fun to watch over the next few days. Going out to grab some popcorn.
Wow, excellent News in today's press release!
We could not have hoped for anything more! The shrinking of these aggressive cancers is amazing. There are very few options today for patients with these aggressive cancers. As long as toxicity continues to be tolerable in further tests, we could be on a fast track to getting this treatment approved! The FDA has committed in the recent past to aggressively bring drugs through the approval process where patients have currently few, if any, options.
This is huge. Period.
No volume. Just mm games. No worries here.
I'm not sure why people are doubting the June 19 shareholder update. The company said their research partners found initial exciting results. That was the quote. They are now accountable for that quote. If they were not honest, the repercussions for the stock will be huge. I have to trust that press release because I highly doubt that they would go as far to claim that the results were exciting without data to back that up. I think they realize they have too much going for them to jeopardize everything they have been working toward. They could have issued any number of other explanations if the results were not good. Just IMO, but I'm long PPCH and I trust they really do have exciting news to share in time.